Twist Bioscience

TWST

ATLANTA, GA – – (ACCESSWIRE – November 16, 2022) – – Holzer & Holzer, LLC is investigating whether Twist Bioscience Corporation (“Twist Bioscience” or the “Company”) (NASDAQ: TWST) complied with federal securities laws.  On November 15, 2022, Scorpion Capital published a report alleging Twist Bioscience is an “unsustainable Ponzi-like scheme based on price dumping and customer subsidies to buy revenue and create the illusion of ‘growth.’” Following this report, the Company’s stock price dropped.

If you purchased Twist Bioscience stock and suffered a loss on that investment, you are encouraged to contact Corey Holzer, Esq. at  cholzer@holzerlaw.com  or Joshua Karr, Esq. at jkarr@holzerlaw.com, call our toll-free number at (888) 508-6832, or visit our website at https://holzerlaw.com/case/twist-bioscience/ to discuss your legal rights.

Registration Deadline

Lead Plaintiff Deadline Has Passed

Submit Your Information

Name(Required)
Address
MM slash DD slash YYYY
Shares Purchased(Required)
Number of Shares Acquired
Acquisition Price Per Share
 
MM slash DD slash YYYY
Shares Sold
Number of Shares Sold
Selling Price Per Share
 
By clicking on the button below, I am requesting Holzer & Holzer, LLC send me documents necessary to retain the firm.